Polysaccharide from Radix Et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease Through Modulating Intestinal Microbiota-Related Gut-Liver Axis

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Sep 23

PMID 36142520

Authors

Lixia Li

Xinting Lan

Xi Peng

Shuai Shi

Yanlin Zhao

Wentao Liu

Qihui Luo

Lanlan Jia

Bin Feng

Zhengli Chen

Yuanfeng Zou

Chao Huang

Affiliations

Soon will be listed here.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease worldwide, thus treatments for it have attracted lots of interest. In this study, the Radix et Rhizoma (SMRR) polysaccharide was isolated by hot water extraction and ethanol precipitation, and then purified by DEAE anion exchange chromatography and gel filtration. With a high-fat-diet-induced obesity/NAFLD mouse model, we found that consumption of the SMRR polysaccharide could remarkably reverse obesity and its related progress of NAFLD, including attenuated hepatocellular steatosis, hepatic fibrosis and inflammation. In addition, we also reveal the potential mechanism behind these is that the SMRR polysaccharide could regulate the gut-liver axis by modulating the homeostasis of gut microbiota and thereby improving intestinal function.

Citing Articles

A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation.

Poo C, Lau M, Nasir N, Nik Zainuddin N, Rahman M, Mustapha Kamal S Curr Issues Mol Biol. 2024; 46(10):11460-11502.

PMID: 39451562 PMC: 11506797. DOI: 10.3390/cimb46100682.

Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review.

Pi Y, Fang M, Li Y, Cai L, Han R, Sun W Nutrients. 2024; 16(17).

PMID: 39275156 PMC: 11397228. DOI: 10.3390/nu16172838.

Termite Fungus Comb Polysaccharides Alleviate Hyperglycemia and Hyperlipidemia in Type 2 Diabetic Mice by Regulating Hepatic Glucose/Lipid Metabolism and the Gut Microbiota.

Xiao H, Song X, Wang P, Li W, Qin S, Huang C Int J Mol Sci. 2024; 25(13).

PMID: 39000541 PMC: 11242180. DOI: 10.3390/ijms25137430.

The gut-liver axis in fatty liver disease: role played by natural products.

Ming Z, Ruishi X, Linyi X, Yonggang Y, Haoming L, Xintian L Front Pharmacol. 2024; 15:1365294.

PMID: 38686320 PMC: 11056694. DOI: 10.3389/fphar.2024.1365294.

Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD).

Guo Q, Li Y, Dai X, Wang B, Zhang J, Cao H Nutrients. 2023; 15(17).

PMID: 37686754 PMC: 10489936. DOI: 10.3390/nu15173722.

References

Wang R, Zhao H, Huang J, Wang H, Li J, Lu Y . Challenges and strategies in progress of drug delivery system for traditional Chinese medicine et (Danshen). Chin Herb Med. 2022; 13(1):78-89. PMC: 9476708. DOI: 10.1016/j.chmed.2020.08.001. View

Chambers R, CLAMP J . An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materials. Biochem J. 1971; 125(4):1009-18. PMC: 1178263. DOI: 10.1042/bj1251009. View

Visser J, Rozing J, Sapone A, Lammers K, Fasano A . Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci. 2009; 1165:195-205. PMC: 2886850. DOI: 10.1111/j.1749-6632.2009.04037.x. View

Federico A, Dallio M, Godos J, Loguercio C, Salomone F . Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. Transl Res. 2015; 167(1):116-24. DOI: 10.1016/j.trsl.2015.08.002. View

Dao M, Clement K . Gut microbiota and obesity: Concepts relevant to clinical care. Eur J Intern Med. 2017; 48:18-24. DOI: 10.1016/j.ejim.2017.10.005. View

Polyzos S, Kountouras J, Mantzoros C . Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2018; 92:82-97. DOI: 10.1016/j.metabol.2018.11.014. View

Zou Z, Shen B, Fan J . Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019; 25(11):1764-1772. DOI: 10.1093/ibd/izz043. View

Zaldivar M, Pauels K, von Hundelshausen P, Berres M, Schmitz P, Bornemann J . CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology. 2010; 51(4):1345-53. DOI: 10.1002/hep.23435. View

Rahman K, Desai C, Iyer S, Thorn N, Kumar P, Liu Y . Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. Gastroenterology. 2016; 151(4):733-746.e12. PMC: 5037035. DOI: 10.1053/j.gastro.2016.06.022. View

10.

Mehlem A, Hagberg C, Muhl L, Eriksson U, Falkevall A . Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc. 2013; 8(6):1149-54. DOI: 10.1038/nprot.2013.055. View

11.

Austarheim I, Christensen B, Hegna I, Petersen B, Duus J, Bye R . Chemical and biological characterization of pectin-like polysaccharides from the bark of the Malian medicinal tree Cola cordifolia. Carbohydr Polym. 2014; 89(1):259-68. DOI: 10.1016/j.carbpol.2012.03.005. View

12.

Siebler J, Galle P, Weber M . The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH. J Hepatol. 2008; 48(6):1032-4. DOI: 10.1016/j.jhep.2008.03.007. View

13.

Dao M, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger E . Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2015; 65(3):426-36. DOI: 10.1136/gutjnl-2014-308778. View

14.

Choi S, Ryu S, Park J, Jeong E, Park J, Ham S . Anti-obesity effect of robusta fermented with in high-fat diet-induced obese mice. Exp Ther Med. 2017; 14(4):3761-3767. PMC: 5639269. DOI: 10.3892/etm.2017.4990. View

15.

Katoh K, Misawa K, Kuma K, Miyata T . MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002; 30(14):3059-66. PMC: 135756. DOI: 10.1093/nar/gkf436. View

16.

Stal P . Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. World J Gastroenterol. 2015; 21(39):11077-87. PMC: 4607906. DOI: 10.3748/wjg.v21.i39.11077. View

17.

Chen W, Wang N, Li R, Xu G, Bao G, Jiang H . Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction. Biomed Pharmacother. 2018; 107:1230-1236. DOI: 10.1016/j.biopha.2018.08.113. View

18.

Henke M, Kenny D, Cassilly C, Vlamakis H, Xavier R, Clardy J . , a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A. 2019; 116(26):12672-12677. PMC: 6601261. DOI: 10.1073/pnas.1904099116. View

19.

Bischoff S, Barbara G, Buurman W, Ockhuizen T, Schulzke J, Serino M . Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol. 2014; 14:189. PMC: 4253991. DOI: 10.1186/s12876-014-0189-7. View

20.

Jie Z, Yu X, Liu Y, Sun L, Chen P, Ding Q . The Baseline Gut Microbiota Directs Dieting-Induced Weight Loss Trajectories. Gastroenterology. 2021; 160(6):2029-2042.e16. DOI: 10.1053/j.gastro.2021.01.029. View